Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients - Trial NCT06405243
Access comprehensive clinical trial information for NCT06405243 through Pure Global AI's free database. This Phase 3 trial is sponsored by Beni-Suef University and is currently Not yet recruiting. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Beni-Suef University
Timeline & Enrollment
Phase 3
Jun 30, 2024
Dec 31, 2024
Primary Outcome
ovulation
Summary
The aim of the study is to compare and assess the efficacy of combined letrozole with
 myoinositol, chromium, or L-arginine in infertile women with PCOS. This study will help in
 the investigation of alternative therapeutic modalities for fertility improvement in
 polycystic ovarian syndrome
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06405243
Non-Device Trial